Vienna, Austria

ESTRO 2023

Session

Tuesday
May 16
11:00 - 12:15
Schubert
This house believes that tumour-specific radiosensitisation is an unachievable radiobiological fantasy
Geoff Higgins, United Kingdom;
Paul Span, The Netherlands
The better understanding of tumor biology has led to the development of tumor targeted radiosensitization strategies. The scientific rational underlining these undertakings is based on the differences in how tumor and normal tissues recover from radiotherapy and exploit tumor specific vulnerabilities by combining radiotherapy with specific agents designed to increase radiation response mainly or solely in tumors. Often integrating novel molecular targeted agents, innovative RT combination proposals are manyfold. Despite successful proof of concept studies, applications in the clinic do however lag behind, prompting a critical assessment of the tumor-targeted radiosensitization concept. Opportunities and challenges will be discussed.
4150
Debate
Interdisciplinary
11:03 - 11:18
Anthony Chalmers, United Kingdom
SP-1025
11:18 - 11:33
Conchita Vens, United Kingdom
SP-1026
11:33 - 11:48
Thorsten Rieckmann, Germany
SP-1027
11:48 - 12:03
Philippe Lambin, The Netherlands
SP-1028